Methylprednisolone and 60 Days in Hospital Survival in Coronavirus Disease 2019 Pneumonia.

ABSTRACT:

Objectives

To determine methylprednisolone's dose, duration, and administration from onset of symptoms and association with 60 days in hospital survival of coronavirus disease 2019 pneumonia.

Design

Cohort study.

Setting

Thirteen hospitals in New Jersey, United States during March to June 2020.

Patients

Seven-hundred fifty-nine hospitalized coronavirus disease 2019 patients.

Interventions

We performed a propensity matched cohort study between patients who received methylprednisolone and no methylprednisolone. Patients in the methylprednisolone group were further differentiated into dose (high dose and low dose), duration, and administration from onset of symptoms.

Measurements and main results

In the propensity matched sample, 99 out of 380 (26%)

SUBMITTER: Go RC 

PROVIDER: S-EPMC8291358 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature